MOLECULE HOLDINGS Cash Flow-to-Debt Ratio
MOLECULE HOLDINGS cash flow-to-debt ratio. MOLECULE HOLDINGS (ERV2) has a Cash Flow-to-Debt Ratio of -0.15x as of October 2022, meaning its operating cash flow of €-1.13 Million could theoretically repay 0% of its total liabilities (€7.61 Million) in one year. See MOLECULE HOLDINGS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MOLECULE HOLDINGS (2021–2022)
Cash flow-to-debt ratio of MOLECULE HOLDINGS from 2021 to 2022. Historical debt coverage capacity for MOLECULE HOLDINGS across 2 annual periods. Also explore ERV2 net assets growth trend to track the company's year-over-year net asset growth rate.
MOLECULE HOLDINGS Cash Flow-to-Debt Ratio by Year (2021–2022)
MOLECULE HOLDINGS cash flow-to-debt ratio by year from 2021 to 2022. Year-by-year debt coverage analysis for MOLECULE HOLDINGS. For the full cash flow conversion analysis, see ERV2 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.15x | €-1.13 Million | €7.61 Million | ▲ +72.5% |
| 2021 | -0.54x | €-2.87 Million | €5.32 Million | — |